Omega Therapeutics, Inc. (OMGA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Omega Therapeutics, Inc. (OMGA)
Company Performance

Current Price

as of Oct 16, 2024

$0.90

P/E Ratio

N/A

Market Cap

$49.9M

Description

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerOMGA
  • Price$0.9047+1.20%

Trading Information

  • Market Cap$49.90M
  • Float37.07%
  • Average Daily Volume (1m)212,348
  • Average Daily Volume (3m)198,831
  • EPS-$1.43

Company

  • Revenue$6.31M
  • Rev Growth (1yr)181.16%
  • Net Income-$16.31M
  • Gross Margin71.27%
  • EBITDA Margin-748.22%
  • EBITDA-$15.97M
  • EV$194.92M
  • EV/Revenue30.87
  • P/EN/A
  • P/S7.90
  • P/B1.90
Documents